Every Rose Has Its Thorns: The Impact of Pilot Free Trade Zones on Urban Consumption in China
Review of Development Economics · 02.06.2026
DOI: 10.1111/rode.70171 ↗Kurz gefasst
Fachartikel in der Zeitschrift Review of Development Economics, online erschienen am 02.06.2026. Verfasst von Bei Wang und 2 weiteren Autor:innen. Die Arbeit nennt 89 Literaturangaben. Gefördert von: Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
China's pilot free trade zones (PFTZs) in various cities represent a form of institutional trade openness. This paper employs the staggered establishment of PFTZs as a quasi‐natural experiment to investigate the impact of such zones on urban per capita consumption. The empirical results show that per capita consumption is significantly lower in PFTZ cities than in non‐PFTZ cities. This negative effect operates through rising housing prices and declining wage income, both of which suppress urban consumption. Furthermore, heterogeneity in geographical locations and institutional innovation levels can account for the divergent consumption effects across cities. By documenting the unintended negative consequences of PFTZs on urban consumption in developing economies, this paper enriches the literature on institutional trade openness.
Förderung
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Wang, B., Hua, Y., & Cao, J. (2026). Every Rose Has Its Thorns: The Impact of Pilot Free Trade Zones on Urban Consumption in China. Review of Development Economics. https://doi.org/10.1111/rode.70171
Vancouver
Wang B, Hua Y, Cao J. Every Rose Has Its Thorns: The Impact of Pilot Free Trade Zones on Urban Consumption in China. Review of Development Economics. 2026. doi:10.1111/rode.70171
BibTeX
@article{Wang2026,
author = {Wang, Bei and Hua, Yunxue and Cao, Jia},
title = {Every Rose Has Its Thorns: The Impact of Pilot Free Trade Zones on Urban Consumption in China},
journal = {Review of Development Economics},
year = {2026},
doi = {10.1111/rode.70171}
}
EUVIMED